(Q37041689)

17 August 2017

Incidence and risk factors for verrucae in women (English)

1 reference

17 August 2017

10

Nancy A Hessol

1 reference

17 August 2017

2

Toby Maurer

1 reference

17 August 2017

5

Howard Minkoff

1 reference

17 August 2017

Jacqueline C Dolev

1

1 reference

17 August 2017

Gayle Springer

3

1 reference

17 August 2017

Marshall J Glesby

4

1 reference

17 August 2017

Casey Connell

6

1 reference

17 August 2017

Mary Young

7

1 reference

17 August 2017

Karlene Schowalter

8

1 reference

17 August 2017

Christopher Cox

9

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

17 August 2017

1 reference

17 August 2017

22

1 reference

17 August 2017

10

1 reference

17 August 2017

1213-1219

1 reference

The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Eosinophilic pustular folliculitis: a comprehensive review of treatment options

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Kaposi's sarcoma in HIV-infected patients: treatment options

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Nongenital dermatologic disease in HIV-infected women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Do we still need a cohort study of women with HIV infection?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Cutaneous diseases in human immunodeficiency virus-infected patients referred to the UCLA Immunosuppression Skin Clinic: reasons for referral and management of select diseases.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Dermatopathologic Findings in Patients Infected with HIV

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Prevalence and predictors of skin disease in the Women's Interagency HIV Study (WIHS).

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Impact of highly active antiretroviral therapy on clinical evolution of genital warts in HIV-infected patients

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615554

The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts

4 September 2018

1 reference

12 December 2020

Dermatologic manifestations of HIV infection

1 reference

12 December 2020

Elimination of false-positive signals in enhanced chemiluminescence (ECL) detection of amplified HPV DNA from clinical samples

1 reference

12 December 2020

The Women's Interagency HIV Study. WIHS Collaborative Study Group

1 reference

12 December 2020

Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy

1 reference

12 December 2020

The changing spectrum of the cutaneous manifestations of HIV disease

1 reference

12 December 2020

Skin disease in HIV-positive persons living in Puerto Rico

1 reference

12 December 2020

Cutaneous warts in HIV-positive patients undergoing highly active antiretroviral therapy

1 reference

12 December 2020

10.1097/QAD.0B013E3283021AA3

Identifiers

DOI

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

18525267

1 reference